Company Overview
| Stock Name | 香港醫思醫療集團有限公司 |
|---|---|
| Stock Code | 02138 |
| Company Full Name | 香港醫思醫療集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事提供醫療、準醫療、傳統美容及獸醫服務，銷售護膚及美容產品。 |
| Listing Date | 2016-03-11 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港鰂魚涌英皇道979號太古坊德宏大廈20樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.echealthcare.com |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 3.03 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 2.6% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 74,235,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 2.98 |
|---|---|
| First Day Open | HK$ 3.1 |
| First Day Change | -1.65% |
| First Day Volume | 54949000.0 |
| First Day Turnover | 160996000.0 |
Use of Proceeds
| Use of Proceeds | 1、約266.5百萬港元或約40%將用于在香港及大中華的其他地區成立新的醫學美容服務中心及診所以及通過有機增長擴大我們現有醫學美容服務中心及診所的規模； 2、約166.6百萬港元或約25%將用于在我們發現時機恰當時收購醫學美容中心及醫學美容診所及成立合營公司； 3、約66.6百萬港元或約10%將用于擴張我們的牙科服務業務； 4、約66.6百萬港元或約10%將用于設立我們的皮膚科相關業務線； 5、約33.3百萬港元或約5%將用于升級及提升我們的信息科技系統； 6、余額約66.6百萬港元或約10%將用于補充營運資金及用于其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Overall Coordinators (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (3)
Credit Suisse (Hong Kong) Limited CE AAO017
海通国际证券有限公司 CE AAF806
CGS-CIMB Securities (Hong Kong) Limited CE AAW351
Joint Lead Managers (3)
Credit Suisse (Hong Kong) Limited CE AAO017
海通国际证券有限公司 CE AAF806
CGS-CIMB Securities (Hong Kong) Limited CE AAW351
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 昊海生物科技控股有限公司 | 77,698,290 HKD | — | 2.60% | — | 6 months | 2016-09-11 |
Directors & Management
| Chairman | 鄧志輝 |
|---|---|
| Company Secretary | 蕭鎮邦 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 鄧志輝(61.29%);OrbiMed Advisors III Limited(5.66%) |
|---|
